Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2293 Views
-
Last post by NHE
-
- 6 Replies
- 6376 Views
-
Last post by ElliotB
-
- 0 Replies
- 1329 Views
-
Last post by NHE
-
- 0 Replies
- 3411 Views
-
Last post by NHE
-
- 1 Replies
- 1017 Views
-
Last post by NHE
-
- 1 Replies
- 1511 Views
-
Last post by NHE
-
- 11 Replies
- 3336 Views
-
Last post by NHE
-
- 0 Replies
- 3155 Views
-
Last post by NHE
-
- 0 Replies
- 1356 Views
-
Last post by NHE